Multiple sclerosis (MS) is a neuroinflammatory disease with a relapsing-remitting disease course at early stages, distinct lesion characteristics in cortical grey versus subcortical white matter and neurodegeneration at chronic stages. Here we used single-nucleus RNA sequencing to assess changes in expression in multiple cell lineages in MS lesions and validated the results using multiplex in situ hybridization. We found selective vulnerability and loss of excitatory CUX2-expressing projection neurons in upper-cortical layers underlying meningeal inflammation; such MS neuron populations exhibited upregulation of stress pathway genes and long non-coding RNAs. Signatures of stressed oligodendrocytes, reactive astrocytes and activated microglia mapped most strongly to the rim of MS plaques. Notably, single-nucleus RNA sequencing identified phagocytosing microglia and/or macrophages by their ingestion and perinuclear import of myelin transcripts, confirmed by functional mouse and human culture assays. Our findings indicate lineage-and regionspecific transcriptomic changes associated with selective cortical neuron damage and glial activation contributing to progression of MS lesions.
1
. Immune-mediated cytotoxic damage to oligodendrocytes (OLs) causes demyelination and focal plaque formation 2, 3 accompanied by progressive axonal damage in white matter (WM) 4, 5 , and active MS plaques typically show a rim of inflammation with myelin phagocytosis. MS lesion heterogeneity in WM versus grey matter (GM) compartments suggests that the underlying pathobiology and potential for repair is likely to vary in a region-restricted manner. Cortical GM pathologies include demyelination and damage to the axon, neurite and neuron cell body 6 , particularly in areas underlying meningeal inflammation with plasma cell infiltration [7] [8] [9] . However, whether this process affects all or only a subset of cortical neurons is not well understood 10 . Indeed, cell-type-specific mechanisms of MS lesion progression, including scar formation with slowly expanding WM lesions 11 and cortical atrophy 12 are not well understood.
Single-cell transcriptomic techniques are well-suited for identification of cellular heterogeneity in the human brain; they have recently been applied to individual glial lineages in MS 13, 14 . Here, we applied a multilineage approach to brain-resident populations (neurons, astrocytes, OLs and microglia) to better understand molecular, cellular and spatially restricted substrates of progressive MS pathology. We used frozen human brain samples from patients with MS and controls to perform unbiased isolation of nuclei from cortical and subcortical lesion and non-lesion areas followed by single-nucleus RNA-sequencing (snRNA-seq) 13, 15 and in situ validation of RNA gene expression across large anatomical areas. Our results indicate that genes that are most dysregulated in MS map to vulnerable upper-cortical-layer neurons and reactive glia at the borders of subcortical MS lesions associated with progression in MS.
Molecular changes associated with MS pathogenesis
We used snRNA-seq to profile cortical GM and adjacent subcortical WM MS lesion areas at various stages of inflammation and demyelination, and control tissue from unaffected individuals. We established a pipeline for serial sectioning of entire tissue blocks including lesion and non-lesion GM and WM areas plus meningeal tissue. Tissue sections were screened for RNA integrity number (RIN) of >6.5. Using this criterion, 12 out of 19 MS tissue samples screened from 17 individuals with MS and 9 out of 16 samples screened from control individuals were further processed (Fig. 1a, Supplementary Table 1 ). Confounding variables of age, sex, postmortem interval and RIN were not significantly different between control subjects and individuals with MS (P >0.1, Mann-Whitney U-test).
We optimized and performed unbiased isolation of nuclei using sucrose-gradient ultracentrifugation (Extended Data Fig. 1a ) followed by snRNA barcoding and cDNA sequencing. After quality control filtering, snRNA-seq yielded 48,919 single-nucleus profiles (Fig. 1b, c) . We normalized data and applied several independent analysis techniques. Unbiased clustering identified 22 cell clusters ( Fig. 1c ; note that none of the clusters comprised nuclei captured from only one individual MS or control sample). We detected a median of 1,400 genes and 2,400 transcripts per nucleus, with higher numbers detected in neuronal versus glial populations (Extended Data Fig. 1b, Supplementary Table 2 ).
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Next, we annotated cell clusters on the basis of the expression of lineage marker genes for excitatory and inhibitory cortical neurons, astrocytes, OL lineage cells and microglia, as well as smaller cell populations 16 ( Fig Table 4) , we observed a selective reduction in numbers of ENs of the upper-layer (layer (L)2-L3; L2-L3 EN-A and L2-L3 EN-B) in MS samples with cortical demyelination (Fig. 1e, f) . By contrast, numbers of intermediatelayer (L4) ENs and deep-layer (L5-L6) ENs, high THY1 and NRGNexpressing pyramidal cells, VIP-expressing, somatostatin (SST)-and parvalbumin (PVALB)-expressing INs were similar between MS and control samples (Fig. 1e-f) . MS-associated genes showed greatest differential expression in L2-L3 ENs, followed by L4 ENs and myelinating OLs (Fig. 1g) . Notably, for L2-L3 ENs and OLs, transcriptomic changes distinguished subclusters from MS or control samples (Fig. 1c, e) . In contrast to L2-L3 ENs, gene dysregulation was less pronounced in upper-layer VIP-expressing INs (Fig. 1g) . These findings suggested cell-type vulnerability of L2-L3 CUX2-expressing ENs. Cell-type-speci c differential gene expression analysis showing that L2-L3 ENs have the highest number of dysregulated genes, followed by L4 ENs and OL cells; the fewest differentially expressed genes were found in SST-expressing INs and OPCs. Box plots represent median and interquartile range (IQR) of differentially expressed gene number calculated after downsampling (100 DGE analyses per cell cluster; control, n = 9; MS, n = 12). Wiskers extend to the largest values within 1.5× IQR from box boundaries, outliers are shown as dots, notches represent a 95% confidence interval around the median. Two-tailed Mann-Whitney Utests were performed in e and f (control, n = 9; MS, n = 12); *P ≤ 0.05. Data are presented as mean ± s.e.m. For t-SNE plots, data are shown from a total of 48,919 nuclei (control, n = 9; MS, n = 12).

Selective vulnerability of upper-layer neurons in MS
We investigated changes in CUX2-expressing L2-L3 ENs in MS lesion pathology using unsupervised pseudotime trajectory analysis to identify dynamic gene expression changes. As shown in Fig. 2a , the cell distribution along the trajectory separated control from MS specimens in L2-L3 ENs. Of note, progression along the trajectory correlated with conventional inflammatory lesion staging and the degree of upper-layer cortical demyelination (Fig. 2b , Extended Data Fig. 1c, d ). For example, CUX2-expressing neurons, which localized towards the trajectory end, derived predominantly from samples harbouring late chronic inactive lesions with extensive subpial demyelination versus lesions with less upper cortical demyelination (Fig. 2c) . Trajectory analysis highlighted gene ontology (GO) terms and dynamic upregulation of oxidative stress, mitochondrial dysfunction and cell death pathways in L2-L3 ENs, including FAIM2, ATF4, CLU and B2M (cell stress/death), HSPH1 and HSP90AA1 (heat-shock response), APP, NEFL and UBB (protein accumulation, axon degradation), COX7C, PKM and PPIA (energy metabolism, oxidative stress) and long-noncoding (lnc)RNAs LINC00657 (also known as NORAD) and BCYRN1 (also known as BC200) 17, 18 (Fig. 2d , e, Extended Data Fig. 2a, Supplementary Table 5 ). Conversely, we noted dynamic downregulation of transcripts associated with mitochondrial energy consumption (FARS2), glutamate signalling (GRIA4 and GRM5), potassium or cation homeostasis (KCNB2, KCNN2 and SLC22A10), neuronal signalling (NELL1), axon plasticity (ROBO1) and lncRNA LINC01266 (Fig. 2f) . Neurons from all cortical layers in MS showed enrichment of cell stress pathways compared to controls (Extended Data Fig. 2b, Supplementary Table 6 ). By contrast, PVALB-and VIPexpressing INs showed only one GO term (associated with protein folding) enriched for dysregulated genes. Together, these findings highlighted a selective transcriptomic damage signature for CUX2-expressing neurons in MS.
Loss of CUX2-expressing neurons in MS lesions in situ
We next used large area spatial transcriptomic (LAST) mapping 19 to validate cell-type-specific changes in gene expression. We optimized chromogenic and multiplex small-molecule fluorescence in situ hybridization (smFISH) protocols to overcome high levels of background autofluorescence in WM and GM areas in frozen human brain samples. We achieved a favourable signal-to-noise ratio over tissue sections for neuronal markers CUX2 and SYT1 combined with immunohistochemistry for myelin oligodendrocyte glycoprotein (MOG), and confirmed layer-associated expression of neuronal subtype markers RORB, THY1, TLE4, VIP and SST (Fig. 3a -e, Extended Data Fig. 3a) .
On the basis of the snRNA-seq findings described above, we investigated expression of co-located upper-layer CUX2-and VIP-expressing populations by smFISH in MS and control sections (Fig. 3f) . We found a significant reduction in CUX2-expressing neurons in completely and incompletely demyelinated cortical areas in MS tissue; by contrast, Article reSeArcH numbers of abutting VIP-expressing INs were maintained. Of note, meningeal infiltration of plasma cells expressing IGHG1 and MZB1 (which predominated over SKAP1 + T cells) was a common finding in sulci with underlying demyelination of the upper cortical layer and loss of CUX2-expressing neurons 7, 20 (Extended Data Fig. 3b ). We next used smFISH to validate upregulation of cell stress markers, including PPIA (encoding prolyl isomerase cyclophilin A, Extended Data Fig. 2a ) in MS L2-L3 and L4 ENs. PPIA transcripts were increased in neurons from demyelinated and adjacent cortical lesion areas of normal appearance 21 ( Fig. 3g) . We confirmed upregulation of NORAD in L2-L3 and L4 ENs (Extended Data Fig. 2a ) by chromogenic and fluorescent smFISH, and observed cytoplasmic NORAD accumulation in MS lesions relative to normal-appearing areas with intact myelin (Fig. 3g) . Together, these findings confirm degeneration and selective loss of CUX2-expressing upper-layer ENs in cortical MS lesions, whereas co-located inhibitory and other cortical EN subtypes were relatively preserved.
Distinct spatial macroglial signatures
Previous studies have indicated differential gene expression (DGE) and functionally diverse properties of reactive astrocytes that can be antagonistic or beneficial to repair after injury 22, 23 . We identified astro- Article reSeArcH gliosis by enhanced immunoreactivity for glial fibrillary acidic protein (GFAP) in regions of subcortical demyelinated WM that did not cross into the demyelinated cortex in MS lesions (Extended Data Fig. 4a ). The GFAP signature in demyelinated WM overlapped with CD44-expressing reactive astrocytes 24 ; CD44 was upregulated at the lesion rim in astrocytes that co-expressed CRYAB and MT3 25 (Extended Data Fig. 4a, b) . RFX4 expression was specific to the astrocyte lineage and captured all SLC1A2-expressing GM astrocytes and CD44-expressing WM astrocytes ( Table 3 ). We observed downregulation of regulatory genes encoding proteins that are relevant for glutamate (SLC1A2 and GLUL) and potassium (KCNJ10) 26 homeostasis in cortical GM astrocytes and confirmed expression of GPC5, a marker that co-localizes with RFX4-expressing GM astrocytes, in lesion and non-lesion cortical areas in situ ( Myelinating OLs characterized by myelin gene expression and the transcription factor ST18 (Fig. 1d, Extended Data Fig. 4c ) exhibited the third-highest number of differentially expressed genes (Fig. 1g ), Article reSeArcH consistent with the enriched stress pathways (Extended Data Fig. 4d ) and known cell loss in MS. DGE analysis indicated upregulation of genes associated with the heat-shock response (HSP90AA1) (Extended Data Fig. 4e ), cell stress (FAIM2 and ATF4), iron accumulation (FTL and FTH1) 28 , major histocompatibility complex (MHC) class I upregulation (B2M and HLA-C), ubiquitin-mediated protein degradation (UBB) and NORAD and LINC00844 (Fig. 4h-j, Extended  Data Fig. 2a) . Conversely, we observed downregulation of markers for OL differentiation and myelin synthesis (BCAS1, SGMS1)
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, potassiumcation homeostasis (KCNJ10) 26 , cell-cell interaction (SEMA6A) and formation of the node of Ranvier (GLDN) in MS OLs at lesion borders (Fig. 4h) . Our findings indicate severe cell stress in MS OLs that can be mapped back to periplaque rim areas of subcortical lesions.
Activated phagocytosing cells in MS
On the basis of the marked expansion of microglia in MS samples (Fig. 1e) , we performed hierarchical clustering (Extended Data Fig. 5 ) and observed microglial cells with a homeostatic gene expression signature (P2RY12, RUNX1 and CSF1R) in MS and control samples as well as MS-specific cells with enrichment for transcripts encoding activation markers, complement factors, MHC class II-associated proteins 14 and lipid degradation proteins (ASAH1, ACSL1, DPYD) (Fig. 5a-c Table 5 ). Downregulated genes in MS microglia included synapse-remodelling transcript SYNDIG1 and potassium channel KCNQ3. Marker genes for microglia reactivity (CD68, CD74, FTL and MSR1) co-localized with the lineage microglia marker RUNX1, and mapped such activated cells to chronic active boundaries of subcortical MS lesions (Fig. 5a-c) . MBP-expressing OLs outlined in yellow). c, Immunohistochemistry for CD68 identifies a WM lesion (top left; black star, blood vessel) with upregulation of MSR1 at lesion rims (bottom left). In PPWM region, MSR1 is co-expressed with RUNX1 (bottom right, arrowheads) and FTL (top right, arrowheads). Representative images from different tissue sections (control, n = 3; MS, n = 4). d, e, Human (d; n = 3 individual biopsies; microglia labelled with pHrodo with lamin A/C counterstain) and mouse (e; n = 4 independent cultures; microglia labelled with antibodies against IBA1 and CD68 with DAPI counterstain) myelin-microglia engulfment assays confirming ingestion of Mbp and Plp1 transcripts derived from rat myelin. Note localization to nuclear-perinuclear spaces (white arrowheads). f, Schematic illustrates myelin phagocytosis and uptake into microglial nuclear and perinuclear spaces. g, h, Quantification of smFISH, showing Mbp persistence up to four days after ingestion in mouse microglia (g; 4 independent cultures); note upregulation of Cd163 and downregulation of P2ry12 in phagocytosing mouse microglia (h; 6 independent cultures). i, Upregulation of CD163 and downregulation of P2RY12 in human MS microglia. Two-tailed Mann-Whitney U-tests. Data are mean ± s.e.m. For t-SNE plots, data are from a total of 48,919 nuclei (control, n = 9; MS, n = 12). Violin plots represent DGE (normalized log transformed UMIs) in microglia nuclei (control, n = 159; MS, n = 1,524 (microglial and phagocytosing cells)); box plots represent median and standard deviation of gene expression. 
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Of note, we identified a cluster of microglial cells characterized by phagocytosis and enrichment for OL-specific markers PLP1, MBP and ST18 (Fig. 1c, d, Extended Data Figs. 4c, 5, Supplementary Table 7) , suggesting the possibility that ingested myelin transcripts co-purified with nuclei of phagocytosing cells in MS. To provide functional evidence for putative myelin RNA microglial phagocytosis, we cultured human and mouse microglia exposed to purified myelin from rat brain (Fig. 5d-i) , which contains myelin transcripts 30 (Extended Data Fig. 6 ). Plp1 and Mbp transcripts were observed in intracellular, perinuclear and nuclear compartments of cultured human or mouse microglia one day after exposure to pHrodo-labelled myelin, and ingested Mbp mRNA was observed in mouse microglia up to four days after feeding. In parallel, we observed morphological changes in phagocytosing mouse microglia, differential upregulation of the activation marker Cd163 and downregulation of the homeostatic microglia marker P2ry12 31 ( Fig. 5d-i) . These changes in mouse microglia were reflected in gene expression changes in human MS microglia detected by snRNA-seq (Fig. 5i) . We have created an interactive web browser to analyse cell-type specific expression levels of genes and transcriptomic changes in MS versus control tissue (https://ms.cells.ucsc.edu).
Discussion
MS lesions are heterogeneous in cortical and subcortical areas, and have distinct patterns of inflammatory demyelination 10, 32, 33 . We found cell-type-specific changes in gene expression in regions of cortical neurodegeneration and at the rim of chronic active subcortical lesions involved in progression and cortical atrophy. Our technical finding of the feasibility of snRNA-seq in MS tissue is consistent with recent observations [13] [14] [15] . We used high-quality archival samples from patients, who did not receive modern immunomodulatory therapies; thus, they represent the end point of the natural disease course with relatively early death of patients (30-50 years of age). However, the number of MS samples studied could have resulted in under-reporting of certain lineages.
Computational analysis of DGE and trajectory analysis of a total of 12 MS and 9 control samples pointed most strongly to the neuronal compartment and indicated substantial cellular stress and loss of CUX2-expressing upper-layer ENs in demyelinated and partially remyelinated cortical MS lesions. As such lesions underlie meningeal inflammation with pronounced plasma B cell infiltration, these findings highlight the importance of B cells in progressive MS 7, 8 and that damaged cortical neuron populations may potentially benefit from B-cell-depleting therapies 34 . We validated candidate gene expression using spatial transcriptomics of human MS brain samples. Markers of stressed CUX2-expressing neurons included PPIA (which encodes cyclophilin A) and NORAD, a neuronal lncRNA that helps to stabilize DNA following genomic stress by binding to pumilio and RBMX proteins 17, 35 , as well as other pathways for protein degradation, heat-shock response and metabolic exhaustion 36, 37 . Whereas most transcriptional changes and neuronal cell loss occurred in demyelinated regions, we also observed abnormal gene expression (for example, PPIA) in cortical areas with normal appearance, suggesting a gradient of pathology 38 . While it is possible that in MS, CUX2-expressing projection neurons are damaged by both sustained meningeal inflammation and retrograde axon pathology from juxtacortical WM lesions 33 , additional intrinsic factors might account for their lack of resilience, especially considering that neighbouring inhibitory and ENs of the cortex exhibited relatively little cell loss.
Recent studies have used MS WM lesion snRNA-seq and singlecell RNA-seq to study the OL 13 and microglia 14 lineages and reported subsets linked to MS pathobiology. Here, we used spatial transcriptomics to map dysregulated glial gene expression in cortical and subcortical lesion and non-lesion areas. Transcriptomic changes associated with OL, microglia and astrocyte activation mapped predominantly to the rim areas of chronically active subcortical lesions 11, 39 . In particular, lesion rim OLs 28 showed molecular changes indicating cellular degeneration and iron overload. Notably, stressed myelinating OLs and upper-layer cortical projection neurons both upregulated genes for self-antigen presentation to immune cells (B2M and HLA-C), indicating processes that perpetuate degeneration and inflammation 40, 41 . In another example of spatial diversity in MS, we detected distinct transcripts for cortical astrocytes versus subcortical lesion astrocytes, indicating molecular differences in the tissue microenvironment. Furthermore, we found that snRNA-seq can distinguish phagocytosing cells in MS on the basis of their transport of ingested myelin transcripts into perinuclear structures or the nucleus itself. Future work is needed to determine whether this biology is beneficial or detrimental in disease course, for example, by exacerbating inflammation. In summary, multilineage and spatial gene expression analysis indicates cell-type-specific neuron vulnerability and glial activation patterns relevant to neurodegeneration and MS lesion progression.
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Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available athttps://doi.org/10.1038/ s41586-019-1404-z. to collect 100-μm-thick sections for total RNA and nucleus isolation. Total RNA from 10 mg tissue was isolated using TRIzol (Thermo Fisher) and purified using the RNAeasy Kit (Qiagen) according to the manufacturer's instructions. Next, we performed RNA integrity analysis on the Agilent 2100 Bioanalyzer using the RNA 6000 Pico Kit (Agilent). Only samples with an RNA integrity number (RIN) ≥ 6.5 were used to perform the isolation of nuclei followed by snRNA-seq as samples with lower RIN generated low-quality data. As the result, we excluded 14 samples (7 MS and 7 control samples) and performed snRNA-seq on a total of 12 snap-frozen brain tissue blocks obtained at autopsies from 7 female and 3 male patients with MS (1 primary progressive MS, 9 secondary progressive MS; Supplementary . The homogenate was loaded into a 30-ml thick-polycarbonate ultracentrifuge tube (Beckman Coulter). Then, 9 ml of sucrose solution (1.8 M sucrose, 3 mM MgAc 2 , 1 mM DTT, 10 mM Tris-HCl in DEPC-treated water) was added to the bottom of the tube under the homogenate and centrifuged at 107,000g for 2.5 h at 4 °C. Supernatant was aspirated, and nuclear pellet was incubated in 250 μl of DEPC-treated water-based PBS for 20 min on ice before resuspending the pellet. Suspensions of nuclei were analysed for the presence of debris, nuclei were counted using a haemocytometer and diluted to 2,000 nuclei per μl before performing single-nucleus capture using the 10x Genomics Single-Cell 3′ system (Extended Data Fig. 1a) . Target capture of 4,000 nuclei per sample was used. Control and MS samples were loaded on the same 10x chip to minimize potential batch effects. Single-nucleus libraries from individual samples were pulled and sequenced on the Illumina HiSeq 2500 machine. The 10x nucleus capture and library preparation protocol was carried out according to the manufacturer's recommendation without modification. snRNA-seq data processing with 10x Genomics CellRanger software and data filtering. For library demultiplexing, fastq file generation, read alignment and unique molecular identifier (UMI) quantification, Illumina bcl2fastq v.2.19 and CellRanger software v.1.3.1 were used. CellRanger was used with default parameters, except for using a pre-mRNA reference file (ENSEMBL GRCh38) to ensure capturing intronic reads originating from pre-mRNA transcripts abundant in the nuclear fraction.
Individual expression matrices containing numbers of UMIs per gene in each nucleus were filtered to retain nuclei with at least 500 genes and 1,000 transcripts expressed. Genes expressed in less than three nuclei were filtered out. Mitochondrial RNA genes were filtered out as well to exclude transcripts originating from outside the nucleus and avoid biases introduced by the isolation of nuclei and ultracentrifugation. Individual matrices were combined, UMIs were normalized to the total UMIs per nucleus and log-transformed. Dimensionality reduction, clustering and t-SNE visualization. A filtered log-transformed UMI matrix containing genes expressed in more than five cells was used to perform truncated singular value decomposition with k = 50 using the svd R software package from base package v.3.6.0. A screen plot was generated to select the numbers of significant principle components (PCs) by localizing the last PC before the explained variance reaches plateau. This resulted in selection of 11 PCs. The significant PCs were used to calculate Jaccard distance-weighted nearest neighbour distances; the number of nearest neighbours was assigned to root square of number of nuclei. The resulting graph with Jaccard-weighted edges was used to perform Louvain clustering using the igraph R software package v.1.0.1 43 . To visualize the transcriptomic profiles of nuclei in two-dimensional space, t-SNE was performed using the Python software module MulticoreTSNE v. 1 Table 2 ). Cell-type annotation. Cell types were annotated based on the expression of known marker genes visualized by t-SNE plot, as well as by performing unbiased gene marker analysis (Supplementary Table 3) . For the latter, the Model-based Analysis of Single-cell Transcriptomics (MAST) R package v.1.10.0 45 was used to perform DGE analysis by comparing nuclei in each cluster to the rest of nuclear profiles. Genes with a FDR-adjusted P < 0.05 and at least twofold gene expression upregulation were selected as cell type markers. Subtypes of projection neurons and INs were annotated based on combinatorial expression of inhibitory and excitatory markers and projection neurons and IN subtype markers. Quantification of number of cell for cell types in MS and control samples. To get insight into enrichment or depletion of cell types in MS, numbers of nuclei in each cluster and individuals were normalized to the total number of nuclei captured from each individual. The following formulae were used:
=
Normalization factor
Total nuclei in sample Total nuclei in sample with largest number of total nuclei captured =
Normalized cell number
Raw cell number in a cell type captured from a sample Normalization factor
Then, normalized cell numbers in each sample and cell type were compared between MS and control groups using a Mann-Whitney U-test (Supplementary  Table 4 ). DGE analysis based on repeated down sampling. To estimate the degree to which the disease affects different cell types of the central nervous system, the number of differentially expressed genes between patients with MS and controls was used as a surrogate parameter. We reasoned that the power to identify differentially expressed genes is partially dependent on the number of cells detected in each cluster. Thus, we devised an analytical approach that corrects for cell count based on repeated downsampling to identical cell numbers for each donor-cluster combination. Specifically, 100 iterations of downsampling were performed, for which 20 cells were randomly drawn from each donor for each cluster and combined into synthetic bulk samples as input for a DGE analysis using DESeq2 v.1.20.0 46 . In this case, we favoured a computationally less intensive analysis using DESeq2 without covariates on synthetic bulk samples over MAST to facilitate the execution of a sufficient number of iterations. The results of this screening approach were plotted as notched box plots and relevant differences between clusters were assumed in cases in which notches did not overlap (Fig. 1g) . Notably, very small clusters that had fewer than 4 samples with a minimum of 20 cells available were excluded from the analysis. Trajectory pseudotime analysis. A single-cell trajectory for excitatory cortical layer 2 and 3 (CUX2-expressing) neurons was determined and analysed using the Monocle package v.3 alpha 47 . FDR-corrected P values were calculated using the Monocle 3alpha R package using 5,938 L2-L3 EN nuclei (Supplementary Table 5 ). In brief, single-cell transcriptomes of all CUX2-expressing cells were dimensionally reduced by principal component analysis followed by uniform manifold approximation and projection. Next, an unsupervised trajectory through the reduced space was identified using the SimplePPT algorithm. The root of the resulting tree was set to where most cells of the control samples clustered. Pseudotime values were then automatically assigned to each cell depending on its distance on the trajectory relative to the root node. Moran's I test as implemented in Monocle 3 alpha was used to identify genes significantly regulated over pseudotime. For each gene, the adjusted P value was signed according to the direction of regulation determined by comparing expression in the first 5% of cells in pseudotime with the last 5%. The resulting gene list, ordered by sign-adjusted P value, was the input for gene set enrichment analysis to test for enriched gene ontology (GO) terms using the clusterProfiler package v.3.10.1 48 . Gene sets with a FDR-corrected P < 0.05 were considered to be significantly enriched. The results of the analysis were plotted as a GO term map using the emapplot() function of the clusterProfiler package to cluster terms based on their gene set relation. Clusters of gene sets were annotated with representative labels.
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To analyse enrichment of individual gene sets on a single-cell level, we used the AUCell algorithm 49 . The algorithm measures gene-set enrichment towards the top of an expression-ranked gene list for each cell. The resulting area under the curve values (AUC) were plotted for all cells along pseudotime. DGE analysis using linear mixed-model regression. To identify genes differentially expressed in MS compared to control samples per cell type, P values were calculated and FDR-corrected using MAST. All nuclei from 9 control and 12 MS samples for corresponding cell types were used (Supplementary Table 6 Where cngeneson is gene detection rate (factor recommended in MAST tutorial), Capbatch is 10x capture batch, Seqbatch is sequencing batch, ind is individual label, ribo_perc is ribosomal RNA fraction and mito_perc is mitochondrial RNA fraction.
To identify genes differentially expressed due to the disease effect, likelihood ratio test was performed by comparing the model with and without the diagnosis factor. Genes with at least 10% increase or decrease in expression in MS versus control and an FDR-corrected P < 0.05 were selected as differentially expressed. In addition, we calculated raw fold changes of gene expression by repeating MAST analysis with only the diagnosis factor in the model and filtered out genes with raw fold change of expression less than 7%. The latter filtering step enabled the removal of genes, for which the fold change of expression was heavily dependent on confounding factors, rather than clinical diagnosis. GO analysis for differentially expressed genes. Panther software v.14.0 (http:// geneontology.org, http://pantherdb.org) was used to perform statistical overrepresentation tests for differentially expressed genes with respect to individual clusters. All genes expressed in a given cluster were used as a background list, and GO-term analysis for enriched biological processes was performed. Processes with an FDR-corrected P < 0.05 were considered and sorted by FDR. Heat map data presentation and hierarchical cluster analysis. Hierarchical clustering was performed with the online Morpheus software (Broad Institute, https://software.broadinstitute.org/morpheus) using 1 − Pearson correlation as distance metric and complete clustering of rows (genes) and columns (cells or samples). To perform hierarchical clustering, we used single-nucleus gene expression matrices of cell type markers for lymphocytes, microglia and phagocytes (Extended Data  Fig. 3, 5, Supplementary Table 7) . Immunohistochemistry. In brief, 16-μm-thick cryosections were collected on superfrost slides (VWR) using a CM3050S cryostat (Leica Microsystems) and fixed in either 4% PFA at room temperature or ice-cold methanol. Next, sections were blocked in 0.1 M PBS, 0.1% Triton X-100, 10% goat, horse or donkey serum for 1 h at room temperature. Primary antibody incubations were carried out overnight at 4 °C. The following antibodies were used for immunohistochemistry: mouse anti-MOG (clone 8-18C5, 1:1,000 (1:200 after in situ hybridization), Millipore Sigma), rat anti-GFAP (clone 2.2B10, Thermo Fisher, 1:1,000 (1:200 after in situ hybridization)), rat anti-CD3 (clone CD3-12, Bio-Rad, 1:100), rabbit anti-MZB1 (polyclonal, Thermo Fisher, 1:1,000), rabbit anti-SKAP1 (polyclonal, Sigma-Aldrich, 1:100), mouse anti-CD138 (clone DL-101, Biolegend, 1:100), mouse anti-CD68 (clone 514H12, Bio-Rad, 1:100), mouse anti-NeuN (clone MAB377, Millipore Sigma, 1:1,000). After washing in 0.1 M PBS, cryosections were incubated with secondary antibodies diluted in 0.1M PSB, 0.1% Triton X-100 for 2 h at room temperature. For chromogenic assays, sections were incubated with biotinylated secondary IgG antibodies (1:500, Thermo Fisher) followed by avidin-biotin complex for 1 h incubation (1:500, Vector Labs) and subsequent colour revelation using 3′-diaminobenzidine (DAB) according to the manufacturer's recommendations (DAKO). For immunofluorescence, Alexa fluochrome-tagged secondary IgG antibodies (1:500, Thermo Fisher) were used for primary antibody detection. Slides with fluorescent antibodies were mounted with DAPI Fluoromount-G (Southern Biotech). Negative control sections without primary antibodies were processed in parallel. For diagnostic purposes, haematoxylin and eosin and Luxol fast blue stainings were carried out. Iron staining. Tissue non-haem iron was stained according to previously published protocols 50 . Sections of fixed, frozen human tissue were allowed to warm to room temperature and dried for 15 min in a laminar-flow hood. Endogenous peroxidase activity was quenched by immersion in a solution of 0.3% H 2 O 2 (v/v) in methanol for 20 min and washed three times in deionized water (dH 2 O). Sections were then placed in a solution of fresh 1% (w/v) potassium ferrocyanide (Sigma-Aldrich), pH 1 with HCl for 40 min, followed by three washes in dH 2 Fluorescence multiplex in situ RNA hybridization and human brain tissue optimization. For smFISH on human brain cryosections performed on an automated BOND RX robotic stainer (Leica), the following procedure was used. Fresh snap-frozen human brain tissue was cryosectioned and slides immediately stored at −80 °C. Because human brain tissue often showed high levels of autofluorescence, several treatments were needed to minimize interference with FISH signals. Using spectral analysis, we identified sources of autofluorescence to be mainly lipofuscin in grey matter (emission wavelengths ~450-650 nm) and collagen or elastin in white matter (emission wavelengths ~470-520 nm). Initial experiments in fixed tissue also displayed low levels of formaldehyde-induced fluorescence in the green yellow spectra (~420-470 nm); thus, sections of human brain tissue were not formaldehyde-fixed before storage. On the day of the experiment, with minimal exposure to (room temperature) air to keep oxidation of endogenous fluorescent proteins low, slides were directly transferred from -80 °C into pre-chilled PFA 4% (methanol-free). Following 45-min incubation sections where immediately submerged in boiling citrate buffer (pH 3.0, Sigma-Aldrich) for 15 min to loosen up the recent crosslinking. Slides where then rinsed twice in PBS and dehydrated. To avoid interference of background fluorescence, experiments were designed so that low-expressing probes were detected using fluorophores with low background, that is, Opal 570, Opal 650. All samples in this study were treated in the same way regardless of disease stage and age. The assay was then performed for 2-3 genes by FISH using the RNAScope LS Multiplex Assay (Biotechne).
Samples were initially permeabilized with heat and protease treatment to improve probe penetration and hybridization. For heat treatment, samples were incubated in BOND ER2 buffer (pH 9.0, Leica) at 95 °C for 10 min. For protease treatment, samples were incubated in ACD protease reagent at 42 °C for 10 min. Before probe hybridization, samples were incubated in hydrogen peroxide for 10 min to inactivate endogenous peroxidases and ACD protease. Subsequently, samples were incubated in target z-probe mixtures (C1-C4) for 2 h at 42 °C. Each slide wash flushed three times in order to obtain optimal hybridization to transcripts. The following human RNAScope LS assay probes were used: SYT1, CUX2, LINC00657, B2M, CD74, RUNX1, RFX4, SLC1A2, CD44, PLP1 and MBP.
Following hybridization, branched DNA amplification trees were built through sequential incubations in AMP1, AMP2 and AMP3 reagents for 15-30 min each at 42 °C with LS Rinse buffer (Leica) high-stringency washes between incubation steps. After amplification, probe channels were detected sequentially via HRP-TSA labelling. Here, samples were incubated in channel-specific HRP reagents for 15 min at 42 °C, TSA fluorophores for 30 min and HRP blocking reagent for 15 min at 42 °C. Probes were labelled using Opal 520, 570 and 650 TSA fluorophores (Perkin Elmer, 1:300). Directly following FISH assay, localization of MOG myelin protein was performed by BOND RX assisted immunohistochemistry, where samples were incubated with anti-MOG antibody (clone 8-18C5, Millipore Sigma) in blocking solution for 1 h (1:200). To develop the antibody signal, samples were incubated in donkey anti-mouse HRP (Abcam, 1:500) for 1 h, TSA-biotin (Perkin Elmer, 1:200) for 10 min and streptavidin-conjugated Alexa 700 (Sigma-Aldrich, 1:200) for 30 min. PCR for myelin and neuron transcripts from rat myelin preparations. RNA from myelin was purified using phenol-chloroform extraction by adding 100 μl of chloroform (Sigma-Aldrich) to 500 μl of Tri-Reagent containing 50 μl of enriched rat myelin derived from the central nervous system. Samples were vortexed and centrifuged at 12,000g max for 15 min at 4 °C. The upper aqueous phase was collected and an equal volume of 70% ethanol added and vortexed. RNA was purified using PureLink RNA Mini-Kit (Thermo Fisher) according to the manufacturer's instructions. RNA was eluted with 30 μl of RNase free water and concentration determined using a SPECTROStar Nano. cDNA was synthesized from 0.3 μg of RNA Amplified products were loaded onto 1% E-Gel (Thermo Fisher) according to the manufacturer's instructions and imaged using an E-Gel imager (Thermo Fisher). Western blot and Coomassie staining for myelin and neuron protein from rat myelin preparations. In brief, 15-20 μg of protein were separated on 4-12% Bis-Tris NuPAGE gels (Thermo Fisher) according to the manufacturer's instructions. Gels were either stained for total protein using 0.3% w/v brilliant blue-G (Sigma-Aldrich) in 40% v/v methanol and 7% v/v glacial acetic acid overnight. Destaining was done with several washes in 40% v/v methanol and 7% v/v glacial acetic. For western blotting, proteins in gels were transferred onto PVDF membranes (Millipore Sigma) using Bolt transfer buffer (Thermo Fisher) for 1 h at 15 V constant voltage. Membranes were blocked with Li-Cor Blocking Buffer (Li-Cor) for 1 h at room temperature on a platform shaker. Membranes were incubated overnight in primary antibodies (1:2,000 dilution) rabbit anti-MBP (clone D8X4Q, Cell Signaling), rabbit anti-MOG (clone E5K6T, Cell Signaling), rabbit-anti neurofilament heavy (NF200, Millipore Sigma) or mouse anti-synaptophysin (clone SY38, Millipore Sigma) in 50% Li-Cor Blocking buffer in tris-buffered saline (TBS) with tween-20 (0.001% v/v) (TBS-T). Membranes were washed three times with TBS-T and Li-Cor 680-RD secondaries (1:5,000) (Li-Cor) applied in 50% v/v Li-Cor blocking buffer in TBS-T for 1 h at room temperature. Membranes were rinsed three times in TBS-T and imaged on a Li-Cor Odyssey (Li-Cor). Myelin enrichment assay and PCR. Myelin enrichment of adult rat central nervous system was performed according to a previously published study 51 . Unless otherwise stated all buffers were prepared in DEPC-treated water and all procedures carried out at 4 °C. In brief, adult rats were perfused with saline and the brains rapidly dissected, olfactory bulbs removed and kept on ice. Brains were cut into hemispheres, and one hemisphere was used for each preparation. Hemispheres were homogenized using a glass Dounce homogenizer in 6 ml of 0.32 M sucrose prepared in DEPC-treated water with HALT protease inhibitor cocktail without EDTA (Thermo Fisher). Then, 1 ml of homogenate was retained for further biochemical analysis and 6 ml of homogenate loaded on top of 6 ml of 0.85 M sucrose treated with DEPC-treated water with HALT protease inhibitors in 14-ml thin-walled centrifuge tubes (Beckman Coulter). Samples were centrifuged at 75,000g max for 35 min at 4 °C. The interface between 0.85 M and 0.32 M sucrose was collected, resuspended in water and centrifuged at 75,000g max for 15 min at 4 °C. The pellet was subjected to two rounds of osmotic shock by resuspension in water, left on ice for 10 min and centrifuged at 12,500g max for 15 min at 4 °C. The pellet was resuspended in 6 ml of 0.32 M sucrose and overlaid on a bed of 0.85 M sucrose and centrifuged at 75,000g max for 35 min at 4 °C. The purified myelin was collected from the 0.32 M-0.85 M sucrose interface. The myelin was then washed in 10 ml of water and centrifuged at 75,000g max for 35 min at 4 °C and resuspended in either 0.25 M bicarbonate pH 8.3 or TBS pH 7.4 to final volume of 400 μl. Subsequently, 50 μl was retained and 500 μl of Tri-Reagent (Thermo Fisher) was added to preserve the RNA. Protein concentration was measured using BCA Protein Assay (Thermo Fisher) according to manufactures instructions. Animals used for myelin-microglia engulfment assays. Wild-type C57BL/6J mice (stock no. 000664) were obtained from Jackson Laboratories. All animal experiments were carried out at the animal facility at the University of Massachusetts Medical School and approved (no. A-2496-17) by Animal Care and Use Committees (IACUC) and performed under NIH guidelines for proper animal welfare. Purification and treatment of primary mouse microglia. Purified primary brain-derived microglia were obtained from mixed glial cultures by modified standard protocols as described 52 . In brief, cerebral cortices from male and female postnatal day 0.5 C57BL/6J wild-type mice were dissected free of meninges, chopped into small pieces and mechanically dissociated until a single-cell suspension was obtained. Cells were then seeded in 10 ml DMEM (Thermo Fisher) supplemented with 10% FBS (Thermo Fisher) and 1% penicillin-streptomycin (Thermo Fisher) at a density of one brain per 75 cm 2 flask, and cultured for 7 days at 37 °C in humidified 5% CO 2 , 95% air. By shaking the culture flasks for 3 h at 180 r.p.m., loosely adhering microglia were detached. The suspended microglial cells were seeded onto glass coverslips at a density of 80,000 cells per well in a 24-well plate and cultured overnight. Subsequently, 24 h before treatment, cell culture medium was changed to neurobasal medium supplemented with 1× sodium pyruvate, 1× B27 (all from Thermo Fisher), 1× GlutaMAX, 1× penicillinstreptomycin (both from Thermo Fisher), 5 μg/ml insulin, 1× Sato supplement 54 , 5 μg/ml N-acetyl-l-cysteine, 40 ng/ml T3 (all from Sigma-Aldrich), and 10 ng/ml mouse macrophage colony-stimulating factor (Shenandoah). Finally, microglia were treated with 6.45 μg purified myelin fraction from rat brain for 4 h, before myelin was removed and cells were fixed or collected for analysis at the indicated time points. To visualize engulfment of myelin proteins into microglial lysosomes, myelin protein was labelled with pHrodo (Thermo Fisher) under RNase-free conditions according to the manufacturer's recommendations before treatment. Mbp RNA hybridization on primary mouse microglia. RNA in situ hybridization was performed according to the manufacturer's recommendations (Biotechne). In brief, after treatment, cells were fixed with 4% PFA, dehydrated and stored at −20 °C for up to 7 days before further use. Before RNA hybridization, cells were rehydrated, rinsed in PBS and treated with 1:15 diluted Protease III for 15 min at 40 °C. Then, probes against Mbp (Biotechne) were added and incubated for 2 h at 40 °C. Subsequent amplification steps were performed according to the manufacturer's instructions. To confirm specificity of RNA signals, some samples were treated with 10 mg/ml RNaseA (Thermo Fisher) for 1 h at 37 °C before incubation with probes. To immunostain samples following Mbp RNA hybridization, cells were washed in PBS, blocked in 2% normal goat serum supplemented with 0.01% Triton X-100 for 30 min and incubated with the following primary antibodies: rabbit polyclonal anti-Iba1 (Wako Chemicals) and rat monoclonal anti-CD68 (clone FA-11, Bio-Rad) (both 1:100). The following day, cells were incubated with appropriate Alexa Fluor-conjugated secondary antibodies (Thermo Fisher) and mounted with Vectashield containing DAPI (Vector). Random 63× fields of all cultures were imaged using identical settings on a Zeiss Observer Spinning Disk Confocal microscope equipped with diode lasers (405 nm, 488 nm, 594 nm, 647 nm) and Zen Blue acquisition software (Zeiss). For unbiased quantification of Mbp puncta, signals were co-localized to Iba1
+ microglia, the investigator was blinded to treatment of the samples and the number of total puncta as well as signals associated with microglia nuclei (0.5 μm distance from the nucleus) were determined using ImageJ software (NIH). Moreover, 630× z-stacks were acquired with 35-50 steps at 0.22 μm spacing and processed in Imaris (Bitplane) to three-dimensional surface render engulfed signals as previously described 53 . RNA isolation and quantitative PCR with reverse transcription. Total RNA from microglia was extracted using TRIzol (Thermo Fisher) according to manufacturer's recommendations. Then, 500 ng of total RNA was transcribed into cDNA using Power SYBR Green Cells-to-CT Kit (Thermo Fisher) according to the manufacturer's instructions. Relative Cd163 and P2ry12 expression was determined by quantitative PCR in relation to Gapdh housekeeping gene expression using the following forward (F) and reverse (R) primers (Integrated DNA Technologies): Cd163-F: GGGTCATTCAGAGGCACACTG; Cd163-R: CTGGCTGTCCTGTCAAGGCT; P2ry12-F: GTTCTACGTGAAGGAGAGCA; P2ry12-R: CTACATTGGGGTCTCT TCGC; Gapdh-F: TGTCCGTCGTGGATCTGAC; Gapdh-R: CCTGCTTCACCAC CTTCTTG. Human tissue sampling for primary human microglia assays. Human brain tissue was obtained with informed consent under protocol REC 16/LO/2168 approved by the NHS UK Health Research Authority. Adult human brain tissue was obtained from three biopsies (age 17, male, diffuse axonal injury, right frontal lobe; age 61, male, unruptured cerebral aneurysm, right gyrus rectus; age 70, male, normal pressure hydrocephalus, right parietal lobe) taken from the site of neurosurgery resection for the original clinical indication. Tissue was transferred to Hibernate A low fluorescence (HALF) supplemented with 1× SOS (Cell Guidance Systems), 2% Glutamax (Thermo Fisher), 1% penicillin-streptomycin, 0.1% BSA, DNase 1 type IV (40 g/ml), insulin (4g/ml, all Sigma-Aldrich) and pyruvate (220 g/ml, Gibco) on ice and transported to a dedicated BCL 2 laboratory. Dissociation of human brain tissue and purification of human microglia. Brain tissue was mechanically digested in fresh ice-cold HALF supplemented with 1× SOS (Cell Guidance Systems), 2% Glutamax (Thermo Fisher), 1% penicillinstreptomycin, 0.1% BSA, DNase 1 type IV (40 g/ml), insulin (4 g/ml, all SigmaAldrich) and pyruvate (220 g/ml, Gibco). The prepared mix was spun in HBSS+ (Thermo Fisher) at 300g for 5 min and supernatant was discarded. The digested tissue was rigorously triturated at 4 °C and filtered through a 70-μm nylon cell strainer (Falcon) to remove large cell debris and undigested tissue. Filtrate was spun in a 22% Percoll gradient with DMEM F12 (both Sigma-Aldrich) at 800g for 20 min. Supernatant was discarded and the pellet was resuspended in ice-cold supplemented HALF. The isolated cell suspension was incubated with anti-CD11b conjugated magnetic beads (Miltenyi) for 15 min at 4 °C. Cells were washed twice with supplemented HALF and passed through an MS column (Miltenyi). Each sample was washed three times in the column and then extracted. Cells were plated in DMEM F12 with 10% FBS and 0.1% macrophage colony-stimulating factor. Note that all cell culture incubators are regularly tested for mycoplasma contamination. Mbp and Plp1 RNA hybridization on primary human microglia. Purified rat brain myelin extracts from three biological replicates were diluted to 1 mg/ml (total protein) in 0.1 M sodium bicarbonate buffer, pH 8.3 in a volume of 100 μl. The pH-sensitive fluorescent dye succinimidyl ester known as pHrodoRed
